• Meta Health agreed on Oct. 26, 2026, to raise SGD 2.3 million through a private placement of 640,000,000 new ordinary shares.
• The issue price of SGD 0.0036 per share represents a 20% premium to the Oct. 26 volume-weighted average price.
• The new shares will represent 32.65% of enlarged share capital, assuming full completion.
• Estimated net proceeds total SGD 2.19 million, allocating SGD 1.6 million to shareholder debt repayment and SGD 592,000 to working capital.
• Completion requires listing clearance and a three-month shareholder loan repayment extension; conditions must be satisfied by Dec. 31, 2026, unless extended.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Meta Health Ltd. published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: YKUJNDKRMT3DX9DR) on October 26, 2026, and is solely responsible for the information contained therein.